These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7435365)
1. The pharmacists primer on price discrimination. Roberts C Am Pharm; 1980 Oct; NS20(10):32-7. PubMed ID: 7435365 [No Abstract] [Full Text] [Related]
2. Pharmacist dispensing: service or sale? Abood RR Am Pharm; 1980 Oct; NS20(10):25-9. PubMed ID: 7435364 [No Abstract] [Full Text] [Related]
3. The President's price guidelines made easy. Siecker BR Am Pharm; 1980 Apr; NS20(4):49-50. PubMed ID: 7386380 [No Abstract] [Full Text] [Related]
4. Applied price competition in pharmacy practice. Strandberg LR J Pharm Mark Manage; 1989; 3(3):67-75. PubMed ID: 10293374 [TBL] [Abstract][Full Text] [Related]
5. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act. Abood RR Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232 [TBL] [Abstract][Full Text] [Related]
6. Judicial views of the pharmacist's professional status. Fink JL Drug Intell Clin Pharm; 1979 Jan; 13(1):30-6. PubMed ID: 10240008 [No Abstract] [Full Text] [Related]
7. The pharmacist and the FTC: Part I. Simonsmeier LM Pharm Manage Comb Am J Pharm; 1979; 151(2):68-9. PubMed ID: 441148 [No Abstract] [Full Text] [Related]
8. Public policy considerations in the pricing of prescription drugs in the United States. Rucker TD Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895 [No Abstract] [Full Text] [Related]
9. Supreme Court finds government hospitals not exempt from price discrimination charges. Peterson RN Health Law Vigil; 1983 Apr; 6(8):6-8. PubMed ID: 10259089 [No Abstract] [Full Text] [Related]
10. A standard time approach to pharmacist labor allocation for cost of dispensing determination. Dickson WM Pharm Manage Comb Am J Pharm; 1979; 151(4):174-9, 190. PubMed ID: 493377 [No Abstract] [Full Text] [Related]
12. Revamping how pharmacists are paid. Martin S Am Pharm; 1993 Feb; NS33(2):62-5. PubMed ID: 8456748 [No Abstract] [Full Text] [Related]
13. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states. Latham SR J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406 [No Abstract] [Full Text] [Related]
14. Price controls and global pharmaceutical progress. Scherer FM Health Aff (Millwood); 2009; 28(1):w161-4. PubMed ID: 19088103 [TBL] [Abstract][Full Text] [Related]
15. Use of new CPT codes depends on practice arrangement. Thompson CA Am J Health Syst Pharm; 2005 Oct; 62(19):1956, 1962-6. PubMed ID: 16174824 [No Abstract] [Full Text] [Related]
16. Health care cost control by third party payors: fee schedules and the Sherman Act. Kallstrom DW Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068 [No Abstract] [Full Text] [Related]
17. Pharmaceuticals: no duty to disclose price differentials to uninsured customers. Verrecchio A J Law Med Ethics; 2000; 28(4):405-6. PubMed ID: 11317430 [No Abstract] [Full Text] [Related]
19. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy. Paul SH Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270 [No Abstract] [Full Text] [Related]